$INO Recent News Monday's biggest gaining and declining

New Post Public Reply Private Reply Replies (0) Message Board

Apr 10, 2014 at 12:53 PM

$INO Recent News

Monday's biggest gaining and declining stocks 5:45 p.m. Nov. 30, 2009 - MarketWatch
Inovio, Merck gain; Novavax falls 5:26 p.m. Nov. 20, 2009 - Val Brickates Kennedy
Friday's biggest gaining and declining stocks 5:25 p.m. Nov. 20, 2009 - MarketWatch
Onyx, Charles River lead drug stocks lower 12:31 p.m. Aug. 5, 2009 - Val Brickates Kennedy
Mylan, Merck, Bayer lead drug stocks higher 10:35 a.m. July 30, 2009 - Val Brickates Kennedy
Drug stocks retreat as Bayer, Inovio jump 11:31 a.m. July 29, 2009 - Val Brickates Kennedy
Inovio to raise $16.2 million from share sale 6:12 a.m. May 16, 2007 - Simon Kennedy
Inovio to sell 4.59 shjares of unit at $3.52 a share 6:06 a.m. May 16, 2007 - Sarah Turner
Monday's biggest stock gainers and decliners 5:07 p.m. March 26, 2007 - MarketWatch
Inovio: DNA delivery technology lifts HIV vaccine potency 6:23 a.m. March 26, 2007 - Sarah Turner
Innovio: DNA delivery technology lifts HIV vaccine potency 6:06 a.m. March 26, 2007 - Steve Goldstein
Inovio Biomedical started at average at Caris & Co. 10:11 a.m. June 2, 2006 - Tomi Kilgore
Inovio study shows benefit of tumor ablation therapy 7:08 a.m. Nov. 18, 2005 - Aude Lagorce
Inovio: Study shows benefit of tumor ablation therapy 7:01 a.m. Nov. 18, 2005 - Steve Goldstein
Updates, advisories and surprises 10:01 p.m. July 13, 2005 - MarketWatch
Inovio receives $2M milestone payment from Merck 6:41 a.m. July 13, 2005 - Kabir Chibber
Inovio Biomedical to get $2M milestone from Merck 6:17 a.m. July 13, 2005 - Steve Goldstein
Inovio to receive option fee, possible milestones 6:06 a.m. May 12, 2005 - Steve Goldstein
Merck exercises option on Inovio antigen deal 6:05 a.m. May 12, 2005 - Steve Goldstein

I Hear The Shorts Knocking, But, I'm Staying Long On Inovio 12:06 p.m. April 9, 2014 - Seeking Alpha
Inovio Pharmaceuticals (INO) Is Today's Dead Cat Bounce Stock 10:01 a.m. April 9, 2014 - TheStreet.com
Race for Vaccines, Treatments as West Africa Ebola Death Toll Tops 100 12:47 p.m. April 8, 2014 - benzinga.com
ProActive Capital Group's Rebuttal To Richard Pearson 12:45 p.m. April 4, 2014 - Seeking Alpha
Use Options For A Chance To Buy INO At A 42% Discount 11:50 a.m. April 4, 2014 - TheStreet.com
Cramer's Mad Money - 11 Things To Watch In The Week Ahead (3/28/14) 5:28 a.m. March 30, 2014 - Seeking Alpha
Jim Cramer's Top Stock Picks: KMX FINL INO BAC 6:00 a.m. March 29, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan 8:21 p.m. March 28, 2014 - TheStreet.com
Hot Stocks on Thursday, March 27 11:30 a.m. March 28, 2014 - WallStreetSectorSelector
Inovio Pharmaceuticals, Inc. (INO) Worth Watching: Stock Surges 12.7% - Tale of the Tape 9:46 a.m. March 28, 2014 - Zacks.com
Inovio Pharmaceuticals (INO) Surges on Heavy Volume 4:35 p.m. March 27, 2014 - TheStreet.com
Trade-Ideas: Inovio Pharmaceuticals (INO) Is Today's "Barbarian At The Gate" Stock 3:21 p.m. March 27, 2014 - TheStreet.com
Mid-Afternoon Market Update: Inovio Rallies on Vaccine Award; Citigroup Remains Down on Stress Test Results 2:39 p.m. March 27, 2014 - benzinga.com
Interesting INO Put And Call Options For November 22nd 11:00 a.m. March 27, 2014 - TheStreet.com
Behind The Scenes With Proactive, Inovio And Unilife 9:45 a.m. March 27, 2014 - Seeking Alpha
Today's Dead Cat Bounce Stock: Inovio Pharmaceuticals (INO) 9:46 a.m. March 26, 2014 - TheStreet.com
3 Biotechs Expecting Top Line Phase 2 Data Mid 2014 5:33 a.m. March 26, 2014 - Seeking Alpha
Today's Perilous Reversal Stock: Inovio Pharmaceuticals (INO) 10:04 a.m. March 20, 2014 - TheStreet.com
10-K: INOVIO PHARMACEUTICALS, INC. 3:15 p.m. March 17, 2014 - Edgar Online - (EDG = 10Q, 10K)
Earnings Scheduled For March 17, 2014 3:59 a.m. March 17, 2014 - benzinga.com

Active Stocks Coverage -- Research on Mallinckrodt, American Eagle Outfitters, Blackstone, and Inovio Pharma 1:01 p.m. April 8, 2014 - PR Newswire - PRF
Healthcare Companies Announce Awards, Partnerships, Milestone Payments, and Conference Schedules - Analyst Notes on Inovio, LifePoint, Mallinckrodt, Ligand, and Theravance 8:00 a.m. April 2, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals Continues Building Its Senior Team With the Appointment of VP of Quality 4:00 a.m. April 1, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals Recognized with "Best Therapeutic Vaccine" Award at World Vaccine Congress 2014 4:00 a.m. March 26, 2014 - PR Newswire - PRF
Equities Updates, Most Active -- Research on Inovio Pharma, Oi S.A., GameStop, and Banco Bradesco 8:00 a.m. March 19, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals Reports 2013 Fourth Quarter and Year End Financial Results 4:00 a.m. March 17, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals to Report Fourth Quarter and Year End 2013 Financial Results on March 17, 2014 4:00 a.m. March 12, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals Closes $63.3 Million Underwritten Financing 10:49 a.m. March 4, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals Announces Pricing of Public Offering of Common Stock 10:00 a.m. Feb. 27, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals Announces Public Offering of Common Stock 5:01 p.m. Feb. 26, 2014 - PR Newswire - PRF
Inovio's Revolutionary DNA Immunotherapy Product Slated for Trials in 2014, by BrokerBank Securities, Inc. 8:00 a.m. Feb. 26, 2014 - PR Newswire - PRF
Health & Nutritional Stocks in the News - Company Expands Product Diversity Based on Growing Consumer Demand 10:00 a.m. Feb. 25, 2014 - PR Newswire - PRF
Emeritus agrees to be acquired by Brookdale Senior Living; Wal-Mart to spend more than $200M on investigations in the next fiscal year 1:26 a.m. Feb. 24, 2014 - ACCESSWIRE
Inovio Pharmaceuticals to Present at Cowen and Company 34th Annual Health Care Conference 5:00 a.m. Feb. 19, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals Bolsters Research and Clinical Development Leadership as it Advances Cancer & Infectious Disease Immunotherapies 5:00 a.m. Feb. 18, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals to Present at BIO CEO & Investor Conference 5:00 a.m. Jan. 30, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals Unveils Potent New Immune Activator 5:00 a.m. Jan. 23, 2014 - PR Newswire - PRF
Market Technicals Simplified: Inovio Pharma, Sequenom, Nektar Therapeutics, and Discovery Laboratories 8:33 a.m. Jan. 16, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals to Present at Biotech Showcase 2014 Investor Conference 5:00 a.m. Jan. 6, 2014 - PR Newswire
AAAResearchReports.com Pre-Market Technical Analysis: Inovio Pharma, Sequenom, Nektar Therapeutics, and Discovery Laboratories 9:23 a.m. Dec. 17, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Honoring Boston's Architects Changing the Game

Celebrating Architecture's Influencers in Boston Every now and then, a profession needs a wake-up call. Stirring the pot, shaking the roots, call it what you will, but when folks rally together with a shared vision, change doesn't just seem possible — it's inevitable. On November 12, the Boston Society of Architects (BSA) and Architecture in Common (AiC) did just that...

SOCSA: The Future of Safety in Confined Spaces?

Autonomous Tech Meets Safety Regulations Some days innovation hits like a ton of bricks, and here we go again—this time with a gizmo aiming to shake up the safety game in confined spaces. Enter the SOCSA, the Self Operating Confined Space Attendant, designed by a seasoned agriculture worker who's had a ringside seat to enough OSHA rule breaches to fill a book. But ain't...

Retirement Dreams Dashed: 61% Withdraw Early

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

NVIDIA Faces Legal Turbulence: CEO's Exit Sparks Chaos

Jensen Huang's Sudden Exit: A Barrage of Headlines In what feels like a blow delivered by a sledgehammer, NVIDIA is rocked by the abrupt resignation of its iconic co-founder and CEO, Jensen Huang. This isn't some quiet departure into the night. Nope, it's more like a cannonball being fired into the investor lounge, leaving a wreckage for all to navigate through. Huang's...

Perpetua Reports Q3 2026 Results, Progress on Project

A Steady Climb for Perpetua Resources It's like watching a boxer steadily climb the ranks, waiting for the big title fight. That's the scene with Perpetua Resources (NASDAQ:PPTA) as their Q3 2026 financial results hit the wires. No confetti cannons this time, just solid, gritty steps towards a promising future. Q3 Financial Results: A Prudent Path The financials for...

Sino Bio Speeds AI Drug Discovery with 4RISE Launch

AI Meets Real-World Validation In the world of cutting-edge biotech, Sino Biological is turning heads with its latest move. If you're in the game of AI-driven drug discovery, their new 4RISE™ high-throughput wet-lab validation services could be the breakthrough you've been waiting for. Why? Well, the promise of AI is dazzling, but it all boils down to how fast you can...

Windward Bio Surges 68% in Nasdaq Debut

By Ryan Hughes Updated Nov 13, 2026 Category News Views 134

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Fluence Energy Faces Class Action: Investor Insights

Investor Blues: Fluence Under the Weather If you've been keeping an eye on Fluence Energy (NASDAQ:FLNC), you're probably clutching your metaphorical pearls right now. Here's the scoop: on November 2, 2026, the stock took another nosedive—dropping nearly 9%—as the company announced that both CEO Julian Nebreda and CFO Ahmad Pasha had packed their bags. A leadership...

Missoula Inventor Offers Handy Phone Solution on the Move

Adjustable Convenience for the Modern Commuter When you're commuting or just lounging around, less hand strain and more comfort sounds like a no-brainer, right? Well, an inventive soul from Missoula, Montana, just might have cracked this little nut with a gizmo they're calling the COMMUTER PHONE. Imagine never having to juggle your phone during those bumpy moments on the...

PangeAI and Sky Blue Transform Data Center Decisions

Just when you thought the incessant trials of picking a prime data center site couldn’t get any more grueling or expensive, enter PangeAI and its brand-new ally, Sky Blue Impact. These tech firms have partnered up to speed up what has traditionally been a sluggish, pricey process. Here’s the deal: PangeAI’s geospatial AI platform lets Sky Blue dodge the usually...